U.S., March 20 -- ClinicalTrials.gov registry received information related to the study (NCT06884280) titled 'Comparing High and Low Dose Iron Treatments for People on Peritoneal Dialysis: The PALaDIN Study' on Feb. 10.
Brief Summary: Chronic kidney disease affects a significant portion of the UK population, with approximately 3.5 million adults diagnosed. At its most severe stage, end-stage kidney disease, individuals require frequent dialysis treatment. One form of dialysis, known as peritoneal dialysis, involves introducing and removing fluid from the abdominal cavity to help filter out toxins from the body.
The kidneys are involved in various hormonal processes, including those responsible for producing red blood cells, making anaemia...